In Celebrating the 4th Anniversary of ZHT, ZHT Certification Class in 2010 is for healthcare providers as a no-surgery and no-device alternative for sleep apnea patients who could not tolerate with or benefit from standard sleep apnea medical treatment with surgery and CPAP or any oral devices.
Hanover Park, IL (PRWEB) November 2, 2009 -- SleepApneaUSA.net Announced new 2010 Zhou's Hypoxicology Therapy (ZHT) Certification Class for healthcare providers as the no-surgery and no-device alternative for sleep apnea patients who could not tolerate with or benefit from standard sleep apnea medical treatment with surgery and CPAP or any oral devices. With the initial successful introduction of ZHT in 2005 and 2006, Dr. Jin Zhou is celebrating the 4th anniversary of ZHT with 2010 ZHT certification programs for healthcare providers, due to the very promising clinical satisfaction from hundreds of ZHT practitioners in U. S. A. and high demand from both healthcare providers and patient community worldwide.
Sleep apnea has been scientifically reported to be linked with the most of the CDC Top 10 death-cause medical diagnoses and traffic accidents as well as the spending of billions of dollars for treating sleep apnea related medical conditions and from labor production losses by sleep apnea resulted sickness and disabilities. Very sadly, millions of Americans already diagnosed with sleep apnea could not tolerate with or benefit from standard medical treatment by the surgery and CPAP or any oral devices.
According to NIH, National Institute of Health, sleep apnea is a deadly medical condition if not timely diagnosed and properly treated. Sleep apnea is now a popularly known medical diagnosis that has been linked to the most of CDC Top 10 deadly medical conditions, such as stroke, heart attack, hypertension, diabetes and cancer. Lately sleep apnea has been reportedly linked to most commonly seen medical conditions from headache, low back pain, arthritis, erectile dysfunction to obesity, and now the sleep apnea has been reportedly linked to the most mysterious medical conditions, even no common diagnosis and therapy could be indicative for.
It was estimated that more than 95-97% of sleep apnea sufferers were never diagnosed. Even for those patients already diagnosed with sleep apnea, it was reported that only less than 20% of them have good tolerance and compliance with the prescribed gold CPAP therapy, and more than 60% to 80% of patients already diagnosed with sleep apnea have no or poor tolerance with or benefit from standard medical treatment with CPAP or surgery. It was also reported more than 20% of U.S. population may suffer from sleep apnea. As more research worldwide has indicated, from Dr. Jin Zhou's research impression, that more than 90% of population at age of 65 or above, 60 to 80% of adult population and 20% of children population may suffer from sleep apnea in different degrees. The economic value is estimated at more than trillions of dollars for the medical expenses associated with treating sleep apnea related major deadly medical conditions and chronic medical conditions, and the estimated labor production losses due to sleep apnea, as well as deadly accidents due to sleep apnea drivers. It is medically critically important and economically significant that a successful clinical resolution to timely diagnosis and effectively control of, or even cure for, sleep apnea could possibly save millions of lives and hundreds of trillions of dollars worldwide and could possibly revolutionize modern medical practice. That is why NTSB has recently recommended for sleep apnea screening for all commercial pilots and drivers.
It is now reasonably well-known and established that sleep apnea has been linked to most of the CDC top 10 death-cause medical conditions, from heart attack, cancer, stroke to diabetes, however, the original or ultimate cause for sleep apnea is not clearly known at all to the scientists and health care practitioners. Dr. Jin Zhou challenges the popular or mainstream theory in etiology for sleep apnea that obstruction or collapse of upper airway is due to the weak and enlarged soft palate. As a matter of fact, as Dr. Jin Zhou hypothesized, the clinical reality is exactly opposite or completely different, therefore the current mainstream clinical treatment protocol by surgery and CPAP or oral devices are not expected to ultimately cure sleep apnea but simply provide for some limited or short-term relief or temporarily cover up the deterioration of sleep apnea development.
In developing new ZHT, Zhou's Hypoxicology Therapy, Dr. Zhou, observed clinically that trachea caudal displacement (TCD) (windpipe moving downward), instead of weak soft appellate as claimed by the mainstream, resulted from diaphragm malfunction and baroreflex dysfunction, is the main anatomical pathology for snoring, collapse of upper airway and frequent breathing stops during the night for obstructive sleep apnea, and as Dr. Zhou hypothesized, dysfunction of baroreflex, chemoreflex, metabo-reflex, mechanoreflex, psychosomato-reflex and respiration pace-making malfunction due to psychological, environmental and anatomical causations are primarily and intricately responsible for the obstructive and central sleep apnea development. Dr. Zhou further hypothesized that all of these sleep apnea etiological components are primarily controlled or regulated internally by human body but induced externally, therefore, sleep apnea shall be completely reversible primarily through volitional resuscitation, resetting of baroreflex and revitalization of upper airway defense reflex by working through patient body internally instead of externally through surgeries and devices.
ZHT, Zhou's Hypoxicology Therapy, as pioneered by its creator, Dr. Jin Zhou, is a new scientific concept and pioneer (aka, unproven) clinical solution as an alternative approach for sleep apnea. ZHT was noticed to be clinically beneficial not only to those sleep apnea patients but also to those patients with commonly seen medical conditions, from headache to sciatica, and mysteriously hard to treat medical conditions as a result of hypoxia, baroreflex dysfunction and dysautonomia.
Although it is not legally and scientifically permissible to claim ZHT as a standard medical protocol, according to Dr. Jin Zhou, it is clinically and optimistically observed that ZHT therapy shall be safe and effective or otherwise ZHT should be discontinued if a patient is not responding to ZHT with satisfactory and significant results within three sections and with definitely noticeable relief on the first session.
Dr. Jin Zhou, D.C., M.D. (China), a former orthopedic surgeon 21 years ago in China and a licensed chiropractic physician in Illinois for 18 years, is dedicated to developing a revolutionized breakthrough, an extremely simple and super natural therapy that could save millions of lives and trillions of dollars without any medication, surgery and device. He coined the new word, hypoxicology. Dr. Zhou is also a nationally renowned expert in healthcare compliance and reimbursement. Dr. Jin Zhou is the president of ERISAclaim.com.
For more information, please visit http://sleepapneausa.net/ZHT_Certifcation.htm, or contact Dr. Jin Zhou at 630-808-7237.
Read the full story at http://www.prweb.com/releases/2009/11/prweb3146024.htm.
Copyright©2009 Vocus, Inc.
All rights reserved